Clinical Trial Update: Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment

View source ↗

Summary

This completed trial evaluated signal transfer of atrial fibrillation data to guide treatment decisions in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Permanent Atrial Fibrillation | Status: COMPLETED